by Truveta News | Apr 28, 2026 | News
Today, we’re introducing Truveta Intelligence, a new AI-powered experience that delivers real-time insights from continuously refreshed real-world data in minutes, not months. For life sciences, public health, and healthcare organizations, this means something simple...
by Truveta staff | Mar 5, 2026 | News
Clinical trials rarely stall because of science alone. More often, they slow due to recruitment challenges—particularly in rare and clinically complex conditions. When that happens, knowing that eligible patients exist is not enough. Sponsors need to locate eligible...
by Truveta staff | Feb 18, 2026 | News
Real-world evidence is critical for understanding how therapies perform beyond controlled clinical trials. Yet many life sciences organizations rely on fragmented proprietary data that lack the longitudinal clinical context needed to support regulatory, payer, and...
by Truveta News | Jan 27, 2026 | News
Clinical trials remain one of the most resource-intensive stages of drug development. Slow enrollment, protocol amendments, zero-enrollment sites, and incomplete real-world evidence can delay timelines and increase cost—ultimately slowing access to life-changing...
by Truveta News | Jan 13, 2026 | News
Today, we are excited to introduce Truveta Live Link, a breakthrough solution that transforms how life science organizations generate real-world evidence. Truveta Live Link unites a life sciences organization’s proprietary data and continuously updated real-world...
